Skip to content

Predictive value of contrast-enhanced ultrasound for papillary thyroid carcinoma aggressiveness

Predictive value of contrast-enhanced ultrasound for papillary thyroid carcinoma aggressiveness

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100050612
Enrollment
Unknown
Registered
2021-09-01
Start date
2021-09-01
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Papillary thyroid carcinoma

Interventions

Gold Standard:Pathological diagnosis
ultrasound

Sponsors

Beijing Friendship Hospital Affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 65 years; 2. Ultrasonography shows the presence of solid or cystic thyroid nodules, TIRADS class 3 or above nodules (single or multiple), and cystic components in the cystic and solid nodules are less than 25%; 3.0.5cm < maximum diameter of nodule < 2.5cm; 4. Preoperative ultrasound and CEUS examination and complete imaging data; 5. Thyroidectomy + neck lymph node dissection and complete operation records; 6. The postoperative pathological result was papillary thyroid carcinoma.

Exclusion criteria

Exclusion criteria: 1. The thyroid parenchyma is full of nodules without normal thyroid glands; 2. Combined with serious life-threatening primary diseases such as the heart, brain, liver, kidney and hematopoietic system, as well as diseases such as mental illness and skin disease that affect examination, biopsy or surgery; 3. Pregnant, lactating women, those with allergies; 4. Those who are allergic to any component in the contrast medium or have contraindications to the use of the contrast medium; 5. Those who participated in other clinical trials or investigators thought that it was not appropriate to participate in this investigator.

Design outcomes

Primary

MeasureTime frame
Contrast-enhanced ultrasound parameters;SEN, SPE, ACC, AUC of ROC, PPV, NPV;

Countries

China

Contacts

Public ContactHu Xiangdong

Beijing Friendship Hospital Affiliated to Capital Medical University

huxd2005@126.com+86 13520983647

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026